Primary pigmented adrenocortical dysplasia (PPNAD) in the context of the Carney complex causing Cushing syndrome;Primare pigmentierte nodulare adrenokortikale dysplasie (PPNAD) im rahmen des Carney-komplexes als ursache eines cushing-syndroms

Medizinische Klinik

Volumn 95, Issue 4, 2000, Pages 224-230

  Koch, Christian A ^b   Bornstein, Stefan R ^a   Chrousos, George P ^b   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Rm 10N262 ^*

Author keywords

Carney complex; Cushing syndrome; PPNAD

Indexed keywords

ADRENAL CORTEX DISEASE; ADRENALECTOMY; ADULT; ARTICLE; CARNEY COMPLEX; CASE REPORT; CLINICAL EXAMINATION; CUSHING SYNDROME; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ADRENAL CORTEX; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; CONGENITAL ADRENAL HYPERPLASIA; DIFFERENTIAL DIAGNOSIS; DOMINANT GENE; FAMILIAL CANCER; GENETICS; HEART TUMOR; MYXOMA; PATHOLOGY; SKIN TUMOR;

ADRENAL CORTEX; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENES, DOMINANT; HEART NEOPLASMS; HUMANS; MYXOMA; NEOPLASTIC SYNDROMES, HEREDITARY; SKIN NEOPLASMS;

EID: 0034655493     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002112     Document Type: Article

References (56)

1. Allolio B, Schulte HM, Hrsg. Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Stuttgart-New York: Schattauer, 1990.
2. Andrada JA, Murray FT, Andrada EC, et al. Cushing's syndrome and autoimmunity. Arch Pathol Lab Med 1979; 103:244-6.
3. Atkinson AB, McCance DR, Kennedy L, et al. Cyclical Cushing's syndrome first diagnosed after pituitary surgery: a trap for the unwary. Clin Endcrinol (Oxf) 1992;36:297-9.
4. Bailey RE. Periodic hormonogenesis - a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 1971;32:317-27.
5. Birke G, Diczfalusy E, Plantin L. Fluctuations in the excretion of adrenocortical steroids in a case of Cushing's syndrome. J Clin Endocrinol Metab 1956;16;286-90.
6. Bornstein SR, Gonzales-Hernandez JA, Erhart-Bornstein M, et al. Intimate contact of chromaffine and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 1994;78:225-32.
7. Bornstein SR, Stratakis CA, Chrousos GP. Adrenocortical tumors: recent advances in basic and clinical management. Ann Intern Med (in press).
8. Brown RD, van Loon GR, Orth DN, et al. Cushing's disease with periodic homonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab 1973;36:445-51.
9. Carney JA, Gordon H, Carpenter PC, et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64:270-83.
10. Carney JA, Young WF. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992;2:6-21.
11. Carson DJ, Slaon JM, Cleland J, et al. Cyclical Cushing's syndrome presenting as short stature in a boy with recurrent atrial myxomas and freckled skin pigmentation. Clin Endocrinol (Oxf) 1988;28;173-80.
12. Casey M, Mah C, Merliss AD, et al. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 1998:98:2560-6.
13. Chajek T, Romanoff H. Cushing syndrome with cyclical edema and periodic secretion of corticosteroids. Arch Intern Med 1976;136:441-3.
14. Chute AL, Robinson GC, Donohue WL. Cushing's syndrome in children. J Pediatr 1949;34:20-39.
15. Doppman JL, Travis WD, Nieman L, et al. Cushing syndrome due to pirimary pigmented nocular adrenocortical disease: findings at CT and MR imaging. Radiology 1989;172:415-20.
16. Erhart-Bornstein M, Hilbers U. Neuroendocrine properties of adrenocortical cells. Horm Metab Res 1998; 30:436-9.
17. Erhart-Bornstein M, Hinson JP, Bornstein SR, et al. Intraadrenal interactions in the regulation of adrenocortical steroidgenesis. Endocr Rev 1998;19:101-43.
18. Gonzales-Hernandez JA, Bornstein SR, Erhart-Bornstein M, et al. Macrophages within the human adrenal gland. Cell Tissue Res 1994;278:201-5.
19. Gomez-Muguruza MT, Chrousos GP. Periodic Cushing's syndrome in a short boy: usefulness of the ovine corticotropin releasing hormone test. J Pediatr 1989;115: 270-3.
20. Grant CS, Carney JA, Carpenter PC, et al. Primary pigmented nodular adrenocortical disease: diagnosis and management. Surgery 1986;100:1178-84.
21. Green JR, van Hoff W. Cushing's syndrome with fluctuation due to adrenal adenoma. J Clin Endocrinol Metab 1975;41:235-40.
22. Hocher B, Bahr V, Dorfmuller S, et al. Hypercortisolism with non-pigmented micronodular adrenal hyperplasia: transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. Acta Endocrinol (Copenh) 1993;128:120-5.
23. Jordan RM, Ramos-Gabatin A, Kendall JW, et al. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm. J Clin Endocrinol Metab 1982;55:531-7.
24. Köhler G, Anding K, Böhm N. Primary pigmented nodular adrenocortical dysplasia. Pathol Res Pract 1998;194: 201-4.
25. Kovacs K, Horvath E, Feldman PS. Pigmented adenoma of adrenal cortex associated with Cushing's syndrome: light and electron microscopic study. Urology 1976;7:641-5.
26. Lacroix A, Bolte E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Enyl J Med 1992; 327:974-80.
27. Lacroix A, Tremblay J, Touyz RM, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushinq's syndrome, and orhostatic hypotension. J Clin Endocrinol Metab 1997;82:2414-22.
28. Lacroix A, Tremblay J, Rousseau G, et al. Propanolol therapy for ectopic b-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.
29. Leibowitz G, White A, Hadani M, et al. Fluctuating hyper-hypocortisolaemia: a variant of Cushing's syndrome. Clin Endocrinol (Oxf) 1997.46:759-63.
30. Liberman B, Wajchenberg BL, Tambascia MA, et al. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis. J Clin Endocrinol Metab 1976;43:913-8.
31. McArthur RG, Bahn RC, Hayles AB. Primary pigmented adrenocortical nodular dysplasia as a cause of Cushing's syndrome in infants and children. Mayo Clin Proc 1982;57:58-63.
32. Melchionna RH, Moore RA. The pharyngeal pituitary gland. Am J Pathol 1938;14:763-71.
33. Mellinger RC, Smith RW. Studies of the adrenal hyperfunction in 2 patients with atypical Cushing's syndrome. J Clin Endocrinol Metab 1955;16:350-66.
34. Merke D, Bornstein SR, Braddock D, et al. Lymphocytic infiltration and adrenocortical neoplasia in a patient with 21-Hydroxylase deficiency. N Engl J Med (in press).
35. Neville AM, OíHare MJ. The human adrenal cortex. Berlin-Heidelberg-New York: Springer, 1982:130-7.
36. Oates TW, McCourt JP, Friedman WA, et al. Cushing's disease with cyclic hormonogenesis and diabetes insipidus. Neurosurgery 1979;5:598-603.
37. Oelkers W, Bähr V, Hensen J, et al. Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells. Acta Endocrinol (Copenh) 1986;113:370-7.
38. Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing's syndrome in adrenal incidentalomas: comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992;75:826-32.
39. Robyn JA, Koch CA, Montalto J, et al. Cushing's syndrome in childhood and adolescence. J Paediatr Child Health 1997;33:522-7.
40. Ruder HJ, Loriaux DL, Lipsett MB. Severe osteopenia in young adults associated with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). J Clin Endocrinol Metab 1974;39:1138-47.
41. Sakiyama R, Ashcraft MW, van Herle AJ. Cyclic Cushing's syndrome. Am J Med 1984;77:944-6.
42. Sarlis NJ, Chrousos GP, Doppman JL, et al. Primary pigmented nodular adrenocortical disease (PPNAD): reevaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 1997; 82:2037-43.
43. Sarlis NJ, Chrousos GP, Papanicolaou DA, et al. Paradoxical cortisol response to dexamethasone in primary pigmented adrenocortical disease (PPNAD) distinguishes PPNAD from macronodular disease in vivo and is present in vitro (Abstract OR21-6). In: Proc 80th Annual Meeting of the Endocrine Society, New Orleans, LA. Bethesda: Endocrine Society Press, 1998:81.
44. Schweizer-Cagianut M, Froesch ER, Hedinger C. Familial Cushing's syndrome with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). Acta Endocrinol 1980;94:529-35.
45. Schweizer-Cagianut M, Salomon F, Hedinger CE. Primary adrenocortical nodular dysplasia with Cushing's syndrome and cardiac myxomas. A peculiar familial disease. Virchows Arch [Pathol Anat] 1982;397:183-92.
46. Shapiro MS, Shenkman L. Variable hormonogenesis in Cushing's syndrome. QJ Med 1991;79:351-63.
47. Stratakis CA, Carney JA, Liu JP, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996;97:699-705.
48. Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macro-nodular disease) leading to Cushing Syndrome. Horm Metab Res 1998;30:456-63.
49. Stratakis CA. The familial lentiginosis syndromes are emerging from the obscurity imposed by rarity: new genes and genetic loci for multiple tumors and developmental defects. 1st Int Meeting on Carney complex and related disorders, Bethesda, MD, NIH, May 1, 1998. Horm Metab Res 1998:30:285-90.
50. Stratakis CA, Carney JA, Kirschner LS, et al. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease (PPNAD): neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab (in press).
51. Thorner MO, Martin WH, Ragan GE. A case of ectopic ACTH syndrome: diagnostic difficulties caused by intermittent hormone seeretion. Acta Endocrinol (Copenh) 1982;99:364-70.
52. Vagnucci AH, Evans E. Cushing's disease with intemittent hypercortisolism. Am J Med 1986;80:83-8.
53. Watanobe H, Aoki R, Takebe K, et al. In vivo and in vitro studies in a patient with cyclical Cushing's disease showing some responsiveness to bromocriptine. Horm Res 1991; 36:227-34.
54. Wegienka LC, Komarmy LE, Wuepper KD, et al. Cushing's syndrome with adrenal medullary insufficiency and adrenal autoantibodies. Lancet 1966;1:741-3.
55. Willenberg HS, Stratakis CA, Marx C, et al. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N Engl J Med 1998;339:27-31.
56. Wulffraat NM, Drexhage HA, Wiersinga WM, et al. Immunoglobulins of patients with Cushing's syndrome due to pigmented adrenocortical micronodular dysplasia stimulate in vitro steroidogenesis. J Clin Endocrinol Metab 1988;66:301-7.